Virios Therapeutics (VIRI) Tops Q4 EPS by 4c
Virios Therapeutics (NASDAQ: VIRI) reported Q4 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
Virios Therapeutics (NASDAQ: VIRI) reported Q4 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.